Histological analysis of IL-2 induced regression of murine solid SL2-tumors

This publication has 11 references indexed in Scilit:

• Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: Tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages
  Immunobiology, 1992
• Polyethylene‐glycol‐modified interleukin‐2 is superior to interleukin‐2 in locoregional immunotherapy of established guinea‐pig tumors
  International Journal of Cancer, 1992
• Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour
  Cancer Immunology, Immunotherapy, 1991
• Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity
  The Journal of Pathology, 1989
• Tumor necrosis factor α induces early morphologic and metabolic alterations in friend leukemia cell tumors and fibrosarcomas in mice
  International Journal of Cancer, 1988
• Characterization of recombinant glycosylated human interleukin 2 produced by a recombinant plasmid transformed CHO cell line
  FEBS Letters, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
  The Journal of Experimental Medicine, 1986
• Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2
  Science, 1984